COST vs RNA · P/E 55, rev $275.24B vs rev $22.6M
Costco Wholesale Corp (COST) versus Atrium Therapeutics, Inc. Common Stock (RNA) — a side-by-side from cached financials, not a winner call.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Atrium Therapeutics, Inc. Common Stock (RNA) is a biotechnology company listed on NASDAQ.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Latest reported RNA revenue for 2026-06-30 was $22.6M. Net income was -$36.8M. Revenue was up 15.3% from 2026-03-31 to 2026-06-30. RNA currently screens at market cap $217.5M.
COST currently screens at market cap $430.32B and trailing P/E 54.9. RNA currently screens at market cap $217.5M.
Not investment advice. Open the COST and RNA stock pages for the full models.
Not investment advice.